These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1025526)

  • 1. [Lipid metabolism disorders and increased vascular risk due to contraceptive steroids].
    Basdevant A; de Lignieres B; Mauvais-Jarvis P
    Nouv Presse Med; 1976 Apr; 6(17):1469-72. PubMed ID: 1025526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contraceptives and thromboembolism (author's transl)].
    Sato K; Ogino M; Nakabayashi M; Sakamoto S
    Kokyu To Junkan; 1978 Mar; 26(3):212-20. PubMed ID: 349637
    [No Abstract]   [Full Text] [Related]  

  • 3. [Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents].
    Gambini G; Farina G; Arbosti G
    Med Lav; 1976; 67(2):152-7. PubMed ID: 1021708
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of hormonal contraceptives on cardiovascular function].
    Manuilova IA; Dubnitskaia LV; Trutko NS
    Akush Ginekol (Mosk); 1983 Nov; (11):5-8. PubMed ID: 6364872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The doctor, the pill and lipaemic disorders. Reflections following an investigation (author's transl)].
    Dovy D; Vasseur MC; Balvay M; Bergeron P
    Rev Fr Gynecol Obstet; 1976 Apr; 71(4):289-92. PubMed ID: 959709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in relation to oral contraceptive use.
    Helmrich SP; Rosenberg L; Kaufman DW; Strom B; Shapiro S
    Obstet Gynecol; 1987 Jan; 69(1):91-5. PubMed ID: 3796927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Prenatal sex-hormone exposure and congenital limb-reduction defects.
    Lancet; 1976 Aug; 2(7981):372-3. PubMed ID: 60606
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Thromboembolism, oral contraceptives, and oestrogen concentration gradient.
    Mueller H; Stadel BV
    Lancet; 1975 Mar; 1(7908):683-4. PubMed ID: 47105
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of risk factors associated with vascular thrombosis in women on oral contraceptives. Possible role of anti-sex steroid hormone antibodies.
    Beaumont V; Lemort N; Beaumont JL
    Artery; 1983; 11(5):331-44. PubMed ID: 6661039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoprotein changes with oral contraceptives and in pregnancy].
    Ravens KG; Jipp P
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():839-41. PubMed ID: 1029296
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral contraceptives and diabetes].
    Bargero G; Capra Marzani M; Fasano M; Rosso A
    Minerva Med; 1986 May; 77(19):839-42. PubMed ID: 3520394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Side effects and complications of use of hormonal contraceptives (literature survey)].
    Pytel' IuA; Zolotarev II; Tsomyk VG; Datuashvili TD
    Vopr Okhr Materin Det; 1976 Aug; 21(8):79-81. PubMed ID: 997375
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of low-dose oral contraceptives (with low-doses of ethinyl estradiol), widely used in practice].
    Nalbanski B; Tsekova K; Ivanov S
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():20-3. PubMed ID: 11519317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormonal contraception and cancer risk].
    Ebeling K; Göretzlehner G
    Z Arztl Fortbild (Jena); 1985; 79(9):365-7. PubMed ID: 4024671
    [No Abstract]   [Full Text] [Related]  

  • 18. Births following oral contraceptive failures.
    Harlap S; Eldor J
    Obstet Gynecol; 1980 Apr; 55(4):447-52. PubMed ID: 7366901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraception and arterial hypertension].
    Corvol P; Millet D; Keledjian P
    Acquis Med Recent; 1977; ():177-80. PubMed ID: 910596
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possible interference of synthetic estroprogestins with thyroid hormone production].
    Paggi A; Leri O; Evangelista M; Manfredi F; Coarelli C; Loiacono C; Cassone R
    Clin Ter; 1981 Aug; 98(4):349-63. PubMed ID: 7285541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.